Compare Hubbell (HUBB) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hubbell vs ImmunityBio Inc. Common Stock — how do they compare? Hubbell trades at $476.16 (market cap $25.12B), while ImmunityBio Inc. Common Stock trades at $10.52 (market cap $10.51B). The key difference: Hubbell is far larger — about 2.4× ImmunityBio Inc. Common Stock's market cap, and Hubbell pays a 1.19% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hubbell for 3 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| HUBB | IBRX | |
|---|---|---|
Market Cap | $25.12B | $10.51B |
Volume | 784,557 | 10,445,785 |
Sector | Industrials | Health |
52-Week High | $557.85 | $11.55 |
52-Week Low | $407.36 | $1.98 |
Typical Hold Time | 3 Days | 0 Days |
Enterprise Value | $30.28B | $10.97B |
Dividend Yield | 1.19% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hubbell
Hubbell manufactures electrical and utility products used in transmission, distribution, and electrical infrastructure. Its portfolio includes components and systems for utilities, data centers, industrial facilities, and buildings.
Read more on HUBB →About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →
